Young Woman With Breast Cancer and Four Inherited Cancer-Risk Variants

Patient Info: Anonymized, female, Under 40 | Stage IV

Biomarkers: ER 40%; PgR 60%; HER2 0; Ki-67 25%; germline pathogenic variants in ATM, PALB2, PMS2

Metastatic Site: brain

The breast cancer spread rapidly to the brain, and she died within a few months.

PubMed CentralRead more →

Stage IV NSCLC with brain metastasis and organic psychosis: improvement with blonanserin patch

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: brain, bone

As of December 2025, he was living with Stage IV NSCLC and brain metastases; severe organic psychosis linked to brain metastasis improved with blonanserin transdermal patch, allowing discharge on hospital day 53.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Kayleigh's Patient Story

Patient Info: Kayleigh, Female | Stage IV

Metastatic Site: right lung

Kayleigh remained in active treatment for Stage IV colorectal cancer with curative intent; the right-lung nodule and other disease were described as shrinking considerably.

The Patient StoryRead more →

Stage IV squamous lung cancer: complete response followed by fatal bone marrow metastasis

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: with PD-L1 95%. SCC antigen/CYFRA rose at relapse.

Metastatic Site: bone (spine, bilateral humerus, bilateral femur); bone…

As of December 2025, he had died of aspiration pneumonia 1 month after admission for biopsy-confirmed bone marrow metastasis from squamous lung cancer, despite a prior complete response to chemoimmunotherapy and pembrolizumab maintenance.

PubMed CentralRead more →

Extensive-stage small-cell lung cancer with bone metastases: stable response after durvalumab rechallenge

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: bone (axial skeleton and skull)

As of November 2025, the patient continued durvalumab with no recurrent gastritis symptoms, continued response to treatment, and no evidence of disease progression on regular CT and bone-scan surveillance.

PubMed CentralRead more →

Stage IVB EGFR L861R lung adenocarcinoma treated with afatinib, osimertinib, and chemotherapy

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: EGFR L861R mutation; CEA 5.5 ng/mL; CYFRA 21-1 5.1 ng/mL

Metastatic Site: lymph nodes, lung, bone

As of September 2025, the patient remained alive 27 months after diagnosis after multiple EGFR-targeted and chemotherapy lines.

PubMed CentralRead more →

Stage IV NSCLC with brain and leptomeningeal metastases responding to radiotherapy, camrelizumab, GM-CSF, and chemotherapy

Patient Info: Anonymized, Male, 50s | Stage IV

Biomarkers: Lung cancer markers supported adenocarcinoma. PD-L1 negative; no common lung driver found; TMB high; MSI not detected.

Metastatic Site: brain, leptomeningeal disease, left supraclavicular…

As of March 2025, leptomeningeal metastases had complete response, brain lesions had further regression, the lung lesion had decreased from 76 mm to 21 mm, and overall disease remained in partial response with 69 months of progression-free survival since radiotherapy.

PubMed CentralRead more →

Stage IVB SMARCA4-deficient NSCLC with brain metastasis: stable disease after surgery, radiation, chemotherapy, immunotherapy, and bevacizumab

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: SMARCA4/BRG-1 loss with TP53 and other mutations; TMB high; PD-L1 <1%; MSI-H not detected.

Metastatic Site: brain

As of October 2025, the patient had stable disease, no brain recurrence, a controlled left lower-lobe lung lesion, and manageable treatment toxicity while continuing bevacizumab plus pemetrexed maintenance.

PubMed CentralRead more →

Stage IV Pulmonary Lymphoepithelioma-Like Cancer With Pseudoprogression After Immunotherapy and Radiation

Patient Info: Anonymized, female, Under 40 | Stage IV

Biomarkers: EBER positive; no EGFR, ROS1, RAS/RAF or PIK3CA mutations/fusions detected

Through May 2025, follow-up showed no clear evidence of cancer recurrence or metastasis, with progression-free survival exceeding 70 months.

PubMed CentralRead more →

Stage IV ER/PR-positive breast cancer with retinal vein and artery occlusion during endocrine-targeted therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER 70%; PR 100%; HER2-negative; Ki-67 10%

Metastatic Site: bone (cranial vault, right first rib, sternum, D5, D6,…

As of November 2025, she continued care for Stage IV ER/PR-positive breast cancer with bone metastases while also managing severe left-eye retinal vascular occlusion and limited visual recovery.

PubMed CentralRead more →

Stage IV Lung Cancer: Tina's Patient Story

Patient Info: Tina Powell, Female | Stage IV

As of November 2025, Tina was living with Stage IV lung cancer after 27 chemotherapy rounds over 3 years and was receiving an antibody-drug conjugate in a clinical trial.

YouTube (AR search)Read more →

Stage IV Colorectal Cancer: Rylie's Patient Story

Patient Info: Rylie, Female, Under 40 | Stage IV

Metastatic Site: liver

Rylie was recovering from emergency surgery, adapting to an ostomy, and preserving fertility after a new Stage IV colon cancer diagnosis; systemic treatment response was not stated.

The Patient StoryRead more →

I Was Told I Was TOO YOUNG For Breast Cancer!

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: mediastinum; lymph nodes between the lungs

As of November 2025, the patient was living with Stage IV metastatic breast cancer, described as lifelong and requiring ongoing treatment. She had also completed local treatment for a later breast lesion.

YouTube — The Patient StoryRead more →

Stage IV Invasive Lobular Carcinoma: Karen's Patient Story

Patient Info: Karen, Female, 40s | Stage IV

Metastatic Site: bone marrow, lymph nodes

Karen was diagnosed in March 2020 with de novo Stage IV invasive lobular carcinoma involving lymph nodes and bone marrow, after mammograms and ultrasound were clear, and she died in 2024 from a rare metastasis.

Lobular Breast Cancer AllianceRead more →

Stage IV Lung Cancer: Ross's Patient Story

Patient Info: Ross Camidge, Male | Stage IV

Biomarkers: Specific mutation identified; mutation name not reported

Metastatic Site: contralateral lung; mediastinal lymph nodes; bones

After a 2022 Stage IV diagnosis, Dr. Camidge was living with metastatic lung cancer between scans and continuing treatment; he described the disease as neither cured nor actively dying.

The Patient StoryRead more →

Synchronous EGFR-mutated lung adenocarcinoma and metastatic breast cancer: surgery and adjuvant therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Two cancers: lung adenocarcinoma with EGFR exon 19 deletion; breast cancer ER-positive, PR-low, HER2 non-amplified.

Metastatic Site: lung

Follow-up CT on 26 December 2024 showed no recurrence, with disease-free survival estimated at 27 months to 1 April 2025 while on icotinib and letrozole maintenance.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Kailee's Patient Story

Patient Info: Kailee, Female, Under 40 | Stage IV

Metastatic Site: liver; lungs

Kailee was living with Stage IV colorectal cancer, caring for 2 young daughters, and continuing active treatment after receiving 4 rounds of chemotherapy during pregnancy.

The Patient StoryRead more →

Stage IV small cell lung cancer: complete tumor response with recovery from paraneoplastic limbic encephalitis

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: Small-cell lung cancer markers included TTF-1/chromogranin-A with Ki-67 90%. Paraneoplastic testing showed GABA-B receptor IgG positive.

Metastatic Site: adrenal glands, diaphragmatic lymph nodes, lungs,…

After 4 cycles of chemotherapy, PET showed complete tumor response. He was alive, clinically well, fully recovered from neurologic symptoms, and April 2025 brain MRI showed improvement of limbic encephalitis changes with evolution toward hippocampal atrophy.

PubMed CentralRead more →

Stage IV ALK Non-Small Cell Lung Cancer: Laura's Patient Story

Patient Info: Laura, Female | Stage IV

Biomarkers: ALK-positive / ALK-rearranged

Metastatic Site: Not reported

Laura was living with incurable Stage IV ALK-positive NSCLC, continuing targeted therapy and regular CT monitoring after trying multiple TKIs and a clinical trial.

The Patient StoryRead more →

Stage IV EGFR-mutant lung cancer: treatment and follow-up story

Patient Info: Anonymized, Female | Stage IV

Biomarkers: EGFR-mutated

As of November 2025, she was newly living with Stage IV EGFR-mutated lung cancer after starting first-generation targeted therapy on 5 March and managing treatment side effects during the first 3 months.

YouTube (ZH search)Read more →

Synchronous primary squamous lung cancers: long disease control after multimodal therapy, then Stage IVA lung recurrence

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: Squamous lung cancers with PD-L1 20% and no driver mutation detected; P40/P63 markers supported squamous type.

Metastatic Site: bilateral lung metastases at recurrence

As of November 2025, the patient had achieved 72 months of progression-free survival and remained alive at 75 months, but had developed Stage IVA recurrent pulmonary squamous cell carcinoma with bilateral lung metastases and had restarted systemic therapy.

PubMed CentralRead more →

Stage IV ROS1 Non-Small Cell Lung Cancer: Drea's Patient Story

Patient Info: Drea, Female, Under 40 | Stage IV

Biomarkers: ROS1-positive

Metastatic Site: bilateral lungs; spine; pelvis; brain

Drea had about 3 years of good response and quality of life on her first ROS1 TKI; after new lesions appeared, a second TKI was keeping disease under control with manageable symptoms.

The Patient StoryRead more →

Metastatic Gastric Cancer Treatment Complicated by Recurrent Cytokine Release Syndrome

Patient Info: Anonymized, female, 70+ | Stage IV

Metastatic Site: peritoneum, bone

She had a partial response after 6 cycles but later chose to stop chemotherapy because treatment toxicity and declining health were affecting quality of life.

PubMed CentralRead more →

Stage IV Lung Cancer: Regula's Patient Story

Patient Info: Regula, Female, 60s | Stage IV

As of November 2025, Regula had lived about 8 months with metastatic lung cancer, was receiving modern medication in the palliative setting, and described good overall wellbeing, continued work, and regular activity.